Cargando…

Renal disorder and biological treatment in juvenile idiopathic arthritis

Detalles Bibliográficos
Autores principales:	Mateescu, Lidia, Stefan, Mariana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191683/ http://dx.doi.org/10.1186/1546-0096-12-S1-P342

Ejemplares similares

Eight years of experience with biological treatment in juvenile idiopathic arthritis
por: Mourão, A F, et al.
Publicado: (2010)

Juvenile idiopathic arthritis treated with biological therapies
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Impact of biologics on growth in children with juvenile idiopathic arthritis
por: Uettwiller, F, et al.
Publicado: (2011)

Switching to an alternative biological agent in juvenile idiopathic arthritis (I)
por: Remesal, A, et al.
Publicado: (2011)

Switching to an alternative biological agent in juvenile idiopathic arthritis (II)
por: Murias, S, et al.
Publicado: (2011)

Phenotypes of juvenile idiopathic arthritis
por: Rokhlina, Faina, et al.
Publicado: (2014)

The efficacy and safety profile of biologic therapy with etanercept in juvenile idiopathic arthritis
por: Alfantaki, SA, et al.
Publicado: (2011)

PReS-FINAL-2147: Immunological consequences of biologicals in juvenile idiopathic arthritis
por: Swart, JF, et al.
Publicado: (2013)

Early treatment with infliximab in patients with juvenile idiopathic arthritis
por: Sleptsova, TV, et al.
Publicado: (2011)

Juvenile idiopathic arthritis in a child with nijmegen breakage syndrome
por: Gazda, Agnieszka, et al.
Publicado: (2014)

Macrophage activation syndrome during treatment with biological therapy in patients with systemic juvenile idiopathic arthritis
por: Boteanu, Alina Lucica, et al.
Publicado: (2014)

Juvenile idiopathic arthritis: the transition to adulthood
por: Fernandes, Susana, et al.
Publicado: (2014)

Ten years of experience of biologics in juvenile idiopathic arthritis: focus for the reasons of withdrawals
por: Arsenyeva, Svetlana V, et al.
Publicado: (2014)

Multicenter retrospective study of biological tolerance in juvenile idiopathic arthritis (jir-cohort)
por: Cabrera, Natalia, et al.
Publicado: (2014)

TNF inhibitors in the treatment of uveitis in the course of juvenile idiopathic arthritis
por: Opoka-Winiarska, Violetta, et al.
Publicado: (2014)

Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
por: Carolina Da Silva, Ana, et al.
Publicado: (2014)

TH17-phenotypes of juvenile idiopathic arthritis
por: Turtsevich, Inga Z, et al.
Publicado: (2014)

Methotrexate in oligoarticular persistent juvenile idiopathic arthritis
por: Horneff, Gerd, et al.
Publicado: (2014)

Juvenile idiopathic arthritis is a diagnosis of exclusion
por: Alexeeva, Ekaterina, et al.
Publicado: (2014)

Clinical and articular presentation of juvenile idiopathic arthritis
por: Ravichandran, R, et al.
Publicado: (2008)

Ocular threat in juvenile idiopathic arthritis (JIA)
por: Marvillet, I, et al.
Publicado: (2008)

Depression, anxiety and pain in juvenile idiopathic arthritis
por: Erdogdu, D, et al.
Publicado: (2008)

Illness representation in adolescents with juvenile idiopathic arthritis
por: Lelieveld, OTHM, et al.
Publicado: (2008)

Systemic juvenile idiopathic arthritis in the republic of Bashkortostan
por: Malievskiy, VA
Publicado: (2011)

Familial hypercholesterolemia misinterpreted as juvenile idiopathic arthritis
por: Schou, AJ, et al.
Publicado: (2011)

PReS-FINAL-2052: Costs of biologics in juvenile idiopathic arthritis: past, present and future
por: Prince, FH, et al.
Publicado: (2013)

PReS-FINAL-2070: Efficacy of biologic treatments in juvenile idiopathic arthritis with a polyarticular course: an indirect comparison
por: Sawyer, L, et al.
Publicado: (2013)

PReS-FINAL-2019: Tuberculosis infection observed in patients receiving biological DMARDs for treatment of juvenile idiopathic arthritis
por: Sarychev, A, et al.
Publicado: (2013)

Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis
por: Avramovič, Mojca Zajc, et al.
Publicado: (2014)

Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis
por: Albers, HM, et al.
Publicado: (2008)

Prediction of clinical non-response to methotrexate treatment in juvenile idiopathic arthritis
por: Van Dijkhuizen, EH Pieter, et al.
Publicado: (2011)

PReS-FINAL-2146: Trends in prescription of biologics and outcomes of juvenile idiopathic arthritis; results of the Dutch national arthritis and biologicals in children register
por: Otten, MH, et al.
Publicado: (2013)

Ankle arthritis predicts worse outcome in children with juvenile idiopathic arthritis
por: Esbjörnsson, Anna-Clara, et al.
Publicado: (2014)

PReS-FINAL-2133: Drug survival and switching of biological agents in systemic juvenile idiopathic arthritis
por: Woerner, A, et al.
Publicado: (2013)

Juvenile idiopathic arthritis (JIA) and early diagnosis of temporo-mandibular joint (TMJ) disorders
por: Alpigiani, MG, et al.
Publicado: (2008)

Sleep disorders in patients with juvenile idiopathic arthritis as assessed by the sleep disturbance scale for children
por: Khubchandani, RP, et al.
Publicado: (2011)

Intra-articular corticosteroid injections in juvenile idiopathic arthritis
por: Carrasco, Roberto, et al.
Publicado: (2014)

Pain threshold in adolescents with juvenile idiopathic arthritis and fibromyalgia
por: Molina, Juliana, et al.
Publicado: (2014)

Refractory systemic juvenile idiopathic arthritis complicated by coxarthrosis
por: Mellos, Antonio, et al.
Publicado: (2014)

DIssociation of T lymphocyte subpopulations in patients with juvenile idiopathic arthritis
por: Minira, Bulegenova, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_98plnpg1m9i6uvrvm1iqd45fuv